Cargando…

Syndrome of Reversible Cardiogenic Shock and Left Ventricular Ballooning in Obstructive Hypertrophic Cardiomyopathy

BACKGROUND: Cardiogenic shock from most causes has unfavorable prognosis. Hypertrophic cardiomyopathy (HCM) can uncommonly present with apical ballooning and shock in association with sudden development of severe and unrelenting left ventricular (LV) outflow obstruction. Typical HCM phenotypic featu...

Descripción completa

Detalles Bibliográficos
Autores principales: Sherrid, Mark V., Swistel, Daniel G., Olivotto, Iacopo, Pieroni, Maurizio, Wever‐Pinzon, Omar, Riedy, Katherine, Bach, Richard G., Husaini, Mustafa, Cresci, Sharon, Reyentovich, Alex, Massera, Daniele, Maron, Martin S., Maron, Barry J., Kim, Bette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751867/
https://www.ncbi.nlm.nih.gov/pubmed/34634917
http://dx.doi.org/10.1161/JAHA.121.021141
_version_ 1784631768350982144
author Sherrid, Mark V.
Swistel, Daniel G.
Olivotto, Iacopo
Pieroni, Maurizio
Wever‐Pinzon, Omar
Riedy, Katherine
Bach, Richard G.
Husaini, Mustafa
Cresci, Sharon
Reyentovich, Alex
Massera, Daniele
Maron, Martin S.
Maron, Barry J.
Kim, Bette
author_facet Sherrid, Mark V.
Swistel, Daniel G.
Olivotto, Iacopo
Pieroni, Maurizio
Wever‐Pinzon, Omar
Riedy, Katherine
Bach, Richard G.
Husaini, Mustafa
Cresci, Sharon
Reyentovich, Alex
Massera, Daniele
Maron, Martin S.
Maron, Barry J.
Kim, Bette
author_sort Sherrid, Mark V.
collection PubMed
description BACKGROUND: Cardiogenic shock from most causes has unfavorable prognosis. Hypertrophic cardiomyopathy (HCM) can uncommonly present with apical ballooning and shock in association with sudden development of severe and unrelenting left ventricular (LV) outflow obstruction. Typical HCM phenotypic features of mild septal thickening, outflow gradients, and distinctive mitral abnormalities differentiate these patients from others with Takotsubo syndrome, who have normal mitral valves and no outflow obstruction. METHODS AND RESULTS: We analyzed 8 patients from our 4 HCM centers with obstructive HCM and abrupt presentation of cardiogenic shock with LV ballooning, and 6 cases reported in literature. Of 14 patients, 10 (71%) were women, aged 66±9 years, presenting with acute symptoms: LV ballooning; depressed ejection fraction (25±5%); refractory systemic hypotension; marked LV outflow tract obstruction (peak gradient, 94±28 mm Hg); and elevated troponin, but absence of atherosclerotic coronary disease. Shock was managed with intravenous administration of phenylephrine (n=6), norepinephrine (n=6), β‐blocker (n=7), and vasopressin (n=1). Mechanical circulatory support was required in 8, including intra‐aortic balloon pump (n=4), venoarterial extracorporeal membrane oxygenation (n=3), and Impella and Tandem Heart in 1 each. In refractory shock, urgent relief of obstruction by myectomy was performed in 5, and alcohol ablation in 1. All patients survived their critical illness, with full recovery of systolic function. CONCLUSIONS: When cardiogenic shock and LV ballooning occur in obstructive HCM, they are marked by distinctive anatomic and physiologic features. Relief of obstruction with targeted pharmacotherapy, mechanical circulatory support, and myectomy, when necessary for refractory shock, may lead to survival and normalization of systolic function.
format Online
Article
Text
id pubmed-8751867
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-87518672022-01-14 Syndrome of Reversible Cardiogenic Shock and Left Ventricular Ballooning in Obstructive Hypertrophic Cardiomyopathy Sherrid, Mark V. Swistel, Daniel G. Olivotto, Iacopo Pieroni, Maurizio Wever‐Pinzon, Omar Riedy, Katherine Bach, Richard G. Husaini, Mustafa Cresci, Sharon Reyentovich, Alex Massera, Daniele Maron, Martin S. Maron, Barry J. Kim, Bette J Am Heart Assoc Brief Communication BACKGROUND: Cardiogenic shock from most causes has unfavorable prognosis. Hypertrophic cardiomyopathy (HCM) can uncommonly present with apical ballooning and shock in association with sudden development of severe and unrelenting left ventricular (LV) outflow obstruction. Typical HCM phenotypic features of mild septal thickening, outflow gradients, and distinctive mitral abnormalities differentiate these patients from others with Takotsubo syndrome, who have normal mitral valves and no outflow obstruction. METHODS AND RESULTS: We analyzed 8 patients from our 4 HCM centers with obstructive HCM and abrupt presentation of cardiogenic shock with LV ballooning, and 6 cases reported in literature. Of 14 patients, 10 (71%) were women, aged 66±9 years, presenting with acute symptoms: LV ballooning; depressed ejection fraction (25±5%); refractory systemic hypotension; marked LV outflow tract obstruction (peak gradient, 94±28 mm Hg); and elevated troponin, but absence of atherosclerotic coronary disease. Shock was managed with intravenous administration of phenylephrine (n=6), norepinephrine (n=6), β‐blocker (n=7), and vasopressin (n=1). Mechanical circulatory support was required in 8, including intra‐aortic balloon pump (n=4), venoarterial extracorporeal membrane oxygenation (n=3), and Impella and Tandem Heart in 1 each. In refractory shock, urgent relief of obstruction by myectomy was performed in 5, and alcohol ablation in 1. All patients survived their critical illness, with full recovery of systolic function. CONCLUSIONS: When cardiogenic shock and LV ballooning occur in obstructive HCM, they are marked by distinctive anatomic and physiologic features. Relief of obstruction with targeted pharmacotherapy, mechanical circulatory support, and myectomy, when necessary for refractory shock, may lead to survival and normalization of systolic function. John Wiley and Sons Inc. 2021-10-12 /pmc/articles/PMC8751867/ /pubmed/34634917 http://dx.doi.org/10.1161/JAHA.121.021141 Text en © 2021 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Brief Communication
Sherrid, Mark V.
Swistel, Daniel G.
Olivotto, Iacopo
Pieroni, Maurizio
Wever‐Pinzon, Omar
Riedy, Katherine
Bach, Richard G.
Husaini, Mustafa
Cresci, Sharon
Reyentovich, Alex
Massera, Daniele
Maron, Martin S.
Maron, Barry J.
Kim, Bette
Syndrome of Reversible Cardiogenic Shock and Left Ventricular Ballooning in Obstructive Hypertrophic Cardiomyopathy
title Syndrome of Reversible Cardiogenic Shock and Left Ventricular Ballooning in Obstructive Hypertrophic Cardiomyopathy
title_full Syndrome of Reversible Cardiogenic Shock and Left Ventricular Ballooning in Obstructive Hypertrophic Cardiomyopathy
title_fullStr Syndrome of Reversible Cardiogenic Shock and Left Ventricular Ballooning in Obstructive Hypertrophic Cardiomyopathy
title_full_unstemmed Syndrome of Reversible Cardiogenic Shock and Left Ventricular Ballooning in Obstructive Hypertrophic Cardiomyopathy
title_short Syndrome of Reversible Cardiogenic Shock and Left Ventricular Ballooning in Obstructive Hypertrophic Cardiomyopathy
title_sort syndrome of reversible cardiogenic shock and left ventricular ballooning in obstructive hypertrophic cardiomyopathy
topic Brief Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751867/
https://www.ncbi.nlm.nih.gov/pubmed/34634917
http://dx.doi.org/10.1161/JAHA.121.021141
work_keys_str_mv AT sherridmarkv syndromeofreversiblecardiogenicshockandleftventricularballooninginobstructivehypertrophiccardiomyopathy
AT swisteldanielg syndromeofreversiblecardiogenicshockandleftventricularballooninginobstructivehypertrophiccardiomyopathy
AT olivottoiacopo syndromeofreversiblecardiogenicshockandleftventricularballooninginobstructivehypertrophiccardiomyopathy
AT pieronimaurizio syndromeofreversiblecardiogenicshockandleftventricularballooninginobstructivehypertrophiccardiomyopathy
AT weverpinzonomar syndromeofreversiblecardiogenicshockandleftventricularballooninginobstructivehypertrophiccardiomyopathy
AT riedykatherine syndromeofreversiblecardiogenicshockandleftventricularballooninginobstructivehypertrophiccardiomyopathy
AT bachrichardg syndromeofreversiblecardiogenicshockandleftventricularballooninginobstructivehypertrophiccardiomyopathy
AT husainimustafa syndromeofreversiblecardiogenicshockandleftventricularballooninginobstructivehypertrophiccardiomyopathy
AT crescisharon syndromeofreversiblecardiogenicshockandleftventricularballooninginobstructivehypertrophiccardiomyopathy
AT reyentovichalex syndromeofreversiblecardiogenicshockandleftventricularballooninginobstructivehypertrophiccardiomyopathy
AT masseradaniele syndromeofreversiblecardiogenicshockandleftventricularballooninginobstructivehypertrophiccardiomyopathy
AT maronmartins syndromeofreversiblecardiogenicshockandleftventricularballooninginobstructivehypertrophiccardiomyopathy
AT maronbarryj syndromeofreversiblecardiogenicshockandleftventricularballooninginobstructivehypertrophiccardiomyopathy
AT kimbette syndromeofreversiblecardiogenicshockandleftventricularballooninginobstructivehypertrophiccardiomyopathy